NeuroAI™

Accelerating Drug Discovery with  Neural Networks and Machine Learning

We believe.

We believe that in the future all drugs will be designed with Artificial Neural Networks.

NeuroAI™ Advantage



At the core of NeuroAI™ is a multilayer neural network. Our artificial neurons mimic more accurately biological neurons. The neural network architecture used in most applications is based on an antiquated understanding of the way neurons in humans work. McCulloch and Pitts described such a nerve cell as a simple logic gate which receives multiple signals from dendrites and in case the accumulated signal exceeds a certain threshold, the neuron generates an output signal.

 

By implementing and incorporating latest discoveries in neuroscience, we continually enhance and build a more powerful neural network architecture. For example, there are as different populations of interneurons which depending on the circumstances will enhance or even inhibit signals of neurons. The advantage of this new architecture is that it can detect more accurately patterns in the complex multivariate data set of human behavior and cognition.   

NeuroAI™ helps create better medicines faster

We use our AI engine, NeuroAI™, to transform drug discovery. NeuroAI™ is a machine learning-based discovery engine that combines the power of convolutional neural networks (CNN) with massive libraries to discover new small molecule medicines. NeuroAI™ helps rapidly discover and develop medicines and does so with a high success rate. Our AI platform incorporates the most advanced biological and medical knowledge. 

Reinventing Small Molecule Drug Discovery

We help biotech and pharma companies generate new insights, de-risk and accelerate research programs and reduce cost of development.



We build mathematical models of disease and treatment based on knowledge extracted from literature, public and proprietary data sets including real-world patient data.